Does Clinical Decision Support Increase Appropriate Medication Prescribing for Cardiovascular Risk Reduction?

2Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Purpose: To assess the impact of a clinical decision support (CDS) system’s recommendations on prescribing patterns targeting cardiovascular disease (CVD) when the recommendations are prioritized in order from greatest to least benefit toward overall CVD risk reduction. Methods: Secondary analysis of trial data from September 20, 2018, to March 15, 2020, where 70 community health center clinics were cluster-randomized to the CDS intervention (42 clinics; 8 organizations) or control group (28 clinics; 7 organizations). Included patients were medication-naïve and aged 40 to 75 years with ≥1 uncontrolled cardiovascular disease risk factor, with known diabetes or cardiovascular disease, or ≥10% 10-year reversible CVD risk. Results: Among eligible encounters with 29,771 patients, the probability of prescribing a medication targeting hypertension was greater at intervention clinic encounters when CDS was used (34.9% [95% CI, 31.5 to 38.3]) versus dismissed (29.6% [95% CI, 26.7 to 32.6]; P

Cite

CITATION STYLE

APA

Boston, D., Larson, A. E., Sheppler, C. R., O’Connor, P. J., Sperl-Hillen, J. A. M., Hauschildt, J., & Gold, R. (2023). Does Clinical Decision Support Increase Appropriate Medication Prescribing for Cardiovascular Risk Reduction? Journal of the American Board of Family Medicine, 36(5), 777–788. https://doi.org/10.3122/jabfm.2022.220391R2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free